Chakravarthi, with over two decades of experience, has turned Ecobliss India into a pioneer in the field of blister packaging, catering to industries such as pharmaceuticals, food, and FMCG. Apart from his corporate endeavours, he serves as a global ambassador for the World Packaging Organization (WPO), promoting best practices in packaging to reduce environmental impact. He has also been recognised with numerous awards for his contributions to the industry, including honours for innovation and leadership in sustainable packaging. In an interview with BioSpectrum, Chakravarthi shares his perspective and insights into the new and emerging trends in pharmaceutical packaging and the future ahead. Edited excerpts:
Could you tell us about your journey from being the CEO and presently to CMD of Ecobliss India?
The transition to CMD is not a significant milestone as it is business as usual. However, personally, it is a moment of pride, reflecting the trust and faith my team and stakeholders have in me. It allows me to focus on strategic growth, mentorship, and steering Ecobliss India toward greater innovation and sustainability. I believe this position enables me to amplify the company’s vision and legacy in the pharmaceutical packaging sector.
In this role, I see myself as more of a mentor and guide. It’s about empowering my team, encouraging fresh ideas, and ensuring that Ecobliss remains a leader in the pharmaceutical packaging industry. Sustainability and innovation are close to my heart, and this position enables me to champion these values more effectively, aligning the company’s goals with global demands for eco-friendly solutions.
What are your immediate priorities and longterm strategies for steering Ecobliss India’s growth, especially in the pharmaceutical packaging domain?
Esta historia es de la edición BioSpectrum India Jan 2025 de Bio Spectrum.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición BioSpectrum India Jan 2025 de Bio Spectrum.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
Sartorius Stedim Biotech opens new centre for bioprocess innovation in US
Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, has opened its new centre for Bioprocess Innovation in Marlborough, Massachusetts in the US.
Agilent introduces innovative Mito-rOCR assay kit for mitochondrial research
Agilent Technologies Inc. has announced the new MitorOCR Assay Kit.
Qiagen launches AI-extension of Ingenuity Pathway Analysis for automatic interpretation of biological data
Qiagen has announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data.
Parse Biosciences announces expansion of Evercode BCR product line
Parse Biosciences, a leader in scalable single cell sequencing solutions, has announced the expansion of its Evercode BCR product line to enable applications in mice.
New technology for unambiguous detection of HIV genome using tailored fluorogenic tests
A team of scientists at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), has developed a novel diagnostic technology known as the GQ Topology-Targeted Reliable Conformational Polymorphism (GQ-RCP) platform.
Gene mutation likely cause for developing autism in early childhood: RGCB study
Autism, a developmental disorder that causes functional abnormalities in brain development, is caused by a combination of environmental and genetic factors with its symptoms manifesting in childhood as early as the age of two years.
IIIT-Delhi unveils AI platform for discovering molecules that promote healthy ageing
A team of researchers from Indraprastha Institute of Information Technology Delhi (IIIT-Delhi) has developed AgeXtend, a groundbreaking artificial intelligence (AI)-based platform that is set to transform the search for molecules promoting healthy ageing.
RSSDI study lays focus on Yoga and Diabetes Prevention
Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, recently released the landmark study by Research Society for Study of Diabetes in India (RSSDI) on 'Yoga and Diabetes Prevention'.
Dr Alok Khullar steps in as Group CEO of RJ Corp Healthcare
RJ Corp Healthcare, a leading name in the healthcare sector through its renowned entities Cocoon Hospital and Cryoviva Stem Cell Bank, has announced the appointment of Dr Alok Khullar as Group Chief Executive Officer (CEO).
Entod Pharmaceuticals on-boards Dr Anish Desai as Scientific & Research adviser
Mumbai-based Entod Pharmaceuticals has appointed Dr Anish Desai as its Scientific and Research Adviser.
